TAL1-SE-mediated monoallelic overexpression of the TAL1 oncogene leads to the establishment of the T-ALL cell state, which suggests that targeting TAL1 expression or its downstream targets may be a potential therapeutic strategy for treating T-ALL [128]. Here, TAL1 is linked to acute lymphoblastic leukemia.